Collagen Solutions PLC Director/PDMR Shareholding (9947K)

TIDMCOS

RNS Number : 9947K

Collagen Solutions PLC

13 July 2017

'This announcement contains inside information.'

Collagen Solutions Plc

(the "Company")

Director/PDMR Dealing

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that Options over ordinary shares of 1p each, as noted below in the Company ("Ordinary Shares") were granted on 12 July 2017.

The Options have an exercise period of ten years from grant and have an exercise price per Option of 5.25p. The Options vest in full after the normal vesting date of 12 July 2020, upon the closing middle market price per Ordinary Share achieving 10p and positive cash flow from operations being sustained for a period of six months.

 
 Director/PDMR          Position            Number of 
                                             Ordinary 
                                             Shares options 
                                             granted 
                        Chief Executive 
 Jamal Rushdy            Officer            1,700,000 
                        Chief Financial 
 Gillian Black           Officer            1,700,000 
                        PDMR / VP Global 
 Christian Wattengel     R&D                500,000 
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------ 
 a)   Name                            1. Jamal Rushdy 
                                       2. Gillian Black 
                                       3. Christian Wattengel 
---  -------------------------  --------------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------------ 
 a)   Position/status                 1. Chief Executive Officer 
                                       2. Chief Financial Officer 
                                       3. PDMR / VP Global R&D 
---  -------------------------  --------------------------------- 
 b)   Initial notification       Initial 
       /Amendment 
---  -------------------------  --------------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------ 
 a)   Name                       Collagen Solutions Plc 
---  -------------------------  --------------------------------- 
 b)   LEI                        N/a 
---  -------------------------  --------------------------------- 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------ 
 a)   Description of             Option to acquire 1p ordinary 
       the financial              shares in Collagen Solutions 
       instrument, type           Plc 
       of instrument 
                                  N/a 
       Identification 
       code 
---  -------------------------  --------------------------------- 
 b)   Nature of the              Grant of options 
       transaction 
---  -------------------------  --------------------------------- 
 c)   Price(s) and volume(s)       Price (exercise)    Volume(s) 
                                   ------------------  ---------- 
                                    1. 5.25p per 
                                     share              1,700,000 
                                   ------------------  ---------- 
                                    2. 5.25p per 
                                     share              1,700,000 
                                   ------------------  ---------- 
                                    3. 5.25p per 
                                     share              500,000 
                                   ------------------  ---------- 
---  -------------------------  --------------------------------- 
 d)   Aggregated information 
 
 
       - Aggregated volume         N/a 
 
 
       - Price                     N/a 
---  -------------------------  --------------------------------- 
 e)   Date of the transaction    12 July 2017 
---  -------------------------  --------------------------------- 
 f)   Place of the transaction   Outside a trading venue 
---  -------------------------  --------------------------------- 
 

About Collagen Solutions:

Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The capabilities of the Company include the provision of native, soluble and powdered collagen formulations, processed and semi-processed tissues such as pericardium, bone, and blood vessels, and expertise in the development and contract manufacture of collagen components for use as engineered tissue scaffolds and other medical devices. These products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology. Collagen Solutions' unique offering extends beyond material supply and contract services through the highly skilled staff who support customers through the various stages of development and regulatory approval. For additional information, please visit www.collagensolutions.com.

Enquiries:

 
  Collagen Solutions Plc                                            Contact via Walbrook 
 Jamal Rushdy, Chief Executive 
  Officer 
 Gill Black, Chief Financial 
  Officer 
 
 Cenkos Securities plc (Nominated                                     Tel: [phone] 
  Adviser and Broker) 
  Stephen Keys 
  Steve Cox 
  Callum Davidson 
 
 Walbrook PR                               Tel: [phone] or [e-mail] 
 Mike Wort                                                            Mob: [phone] 
 Anna Dunphy                                                          Mob: [phone] 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKNDNKBKDFOD

(END) Dow Jones Newswires

July 13, 2017 06:39 ET (10:39 GMT)